Chief Commercial Officer of Atara Biotherapeutics, Inc. (NASDAQ:ATRA), Yarema Kristin, buys 32,333 shares worth $471,065
According to Atara Biotherapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jun 15 04:02 PM, company Chief Commercial Officer, Yarema Kristin disclosed buying 32,333 shares at a cost of $14.57. At the time of this transaction (Jun 14), this trade was worth $471,065 in total. As of Jun 14, Yarema Kristin now owns 125,882 shares in total worth about $1,762,348.0.
For the last few recent trades made by Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Chief Commercial Officer, Yarema Kristin, we have the following information:
- SEC Form 4 filing: Jun 11: Bought 2,021 shares at the rate of $14.50 per share. Total worth of this trade was $29,304. Total number of shares owned as of Jun 11 were 93,549
Posted by
George Daniels
on Wednesday June 16 2021, 9:46 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
